Purchasing Hep C Drugs at 340B pricing for inmates receiving Hepatitis treatment from VCU providers…

The Virginia Department of Corrections awarded a contract to VCU Health System on July 16, 2026, for the provision of Hepatitis C pharmaceutical treatments to inmates under the 340B drug pricing program. The contract, identified as PO05410252, establishes a cumulative value of $3.5 million for the delivery of Hepatitis C drugs sourced at 340B pricing to inmates receiving treatment through VCU Health System providers. The contract period spans twelve months, from July 1, 2026, through June 30, 2027, with deliverables corresponding to invoices received during this timeframe.

Under this sole line item agreement, VCU Health System will supply pharmaceutical products to support inmate Hepatitis C treatment protocols. The goods are to be delivered to Haseeb Zafar, with the contract structured to cover the full cost of Hepatitis C medications procured at 340B pricing—a federal drug discount program available to eligible entities including teaching hospitals and safety-net providers. This arrangement enables the Department of Corrections to access reduced pharmaceutical costs while ensuring inmates in its custody receive necessary Hepatitis C treatment through VCU Health System's clinical providers.